跳至主要内容
临床试验/CTRI/2025/10/096610
CTRI/2025/10/096610招募中3 期

A Randomised Clinical Trial To Evalaute The Role Of Shankhapushpi Ghrita And Go Ghrita Padabhayanga In Improving The Quality Of Nidra

Dr Sargam Baghel1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2025年12月1日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
72
试验地点
1
主要终点
1. Patients below 18 or above 25 years of age.

研究概览

简要总结

In parallel Padabhyanga therapeutic foot massage with GoGhrita is a cornerstone of Dinacharya daily regimen known to balance Vata dosha and calm the nervous system through Marma stimulation and Snehana oleation The soles of the feet are rich in nerve endings and are connected to vital organs making them a therapeutic site for achieving systemic relaxation While the benefits of both these therapies are well-cited in classical texts and some contemporary anecdotal observations no comprehensive clinical trial has been conducted to evaluate and compare their individual and combined effects on the quality of sleep

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 25.00 Year(s)(—)
性别
All

入选标准

  • Patients willing to give informed consent and follow the treatment protocol.
  • Male and female individuals of 18 to 25 age will be enrolled.
  • Individuals experiencing sleep disturbances for more than 3 weeks .
  • Individuals clinically diagnosed with Quality of nidra (primary insomnia) as per Ayurvedic criteria.
  • Pittsburgh Sleep Quality Index total score between 5 and 21 is indicative of poor sleep quality.

排除标准

  • Exclusion criteria:
  • Patients below 18 or above 25 years of age.
  • Individuals suffering from other metabolic disease due to systemic diseases
  • Patients with psychiatric illnesses such as depression, schizophrenia, or bipolar disorder.
  • Individuals currently taking sedatives, hypnotics, or undergoing any form of insomnia treatment
  • Individuals with neurological disorders (e.g., epilepsy, Parkinson’s disease).

结局指标

主要结局

1. Patients below 18 or above 25 years of age.

时间窗: Base line, 7th and 15th day

2. Individuals suffering from other metabolic disease due to systemic diseases

时间窗: Base line, 7th and 15th day

3. Patients with psychiatric illnesses such as depression, schizophrenia, or bipolar disorder.

时间窗: Base line, 7th and 15th day

4. Individuals currently taking sedatives, hypnotics, or undergoing any form of insomnia treatment

时间窗: Base line, 7th and 15th day

5. Individuals with neurological disorders (e.g., epilepsy, Parkinson’s disease).

时间窗: Base line, 7th and 15th day

次要结局

  • 5. Enhanced sleep efficiency.

研究者

发起方
Dr Sargam Baghel
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

DrSargam Baghel

Bharati Vidyapeeth (Deemed to be University)

研究点 (1)

Loading locations...

相似试验